Amazon develops cancer vaccines in partnership with Fred Hutchinson enrolls patients for trial

Amazon is quietly developing breast and skin cancer vaccines that will be cheaper than current treatments as the company recruits patients for an FDA-approved clinical trial

  • Amazon is developing cancer vaccines in collaboration with Seattle’s Fred Hutchinson Cancer Center and has launched an FDA-approved clinical trial
  • Trial to develop personalized vaccines using patient DNA
  • The vaccine would be used treatment of breast cancer and melanoma skin cancer
  • It could offer more targeted and precise cancer treatment at a lower cost
  • Phase I will be completed by November 2023, but anything coming to market will likely be several years away

Amazon is developing cancer vaccines in collaboration with Seattle-based Fred Hutchinson Cancer Center.

The project is reportedly preparing to start an FDA-approved clinical trial and is enrolling patients.

The trial would focus on the development of personalized vaccines to fight breast cancer and melanoma.

The vaccine could offer more targeted and precise cancer treatment at a lower cost, Insider reports. It can even be a good alternative to chemotherapy which is more widespread.

Amazon is developing cancer vaccines in collaboration with Seattle’s Fred Hutchinson Cancer Center and has launched an FDA-approved clinical trial

News of the partnership was first revealed in October on Clinicaltrials.gov, which contains an online database of clinical studies maintained by the US National Library of Medicine.

The cancer vaccine project emerged from Amazon’s secret Moonshot lab called Grand Challenge. The people involved in Amazon’s cancer research team are said to be a small group of doctors and health technology engineers.

The study only started last month, June 9, and the trial is expected to be completed in early November 2023.

20 patients are expected to participate in the first phase of the trial to test a “pharmaceutical product regulated by the United States FDA”.

The trial focuses on the development of personalized vaccines using patient DNA and Amazon is working with the Fred Hutchinson Cancer Research Center in Seattle

The trial focuses on the development of personalized vaccines using patient DNA and Amazon is working with the Fred Hutchinson Cancer Research Center in Seattle

Whereas Fred Hutchinson is listed as the trial sponsor, Amazon is named as the study “collaborator”.

Both Fred Hutchinson and Amazon have confirmed that they are working on the trial with the company in partnership with other healthcare companies.

“Amazon is bringing its scientific and machine learning expertise to a partnership with Fred Hutch to explore the development of personalized treatment for certain forms of cancer. It’s very early days, but Fred Hutch recently received clearance from the US Food and Drug Administration to proceed with a Phase I clinical trial, and it’s unclear if he will be successful,’ the spokesperson said. from Amazon in an email to Insider.

“This will be a long, multi-year process – if it progresses, we would be open to working with other healthcare and life science organizations that may also be interested in similar efforts.”

It’s the first time Amazon has worked on its own drug, although the company has recently shown greater interest in healthcare.

It's the first time Amazon has worked on its own drug, although the company has recently shown greater interest in healthcare.  Pictured, the exterior of the spheres can be seen at Amazon's headquarters in Seattle

It’s the first time Amazon has worked on its own drug, although the company has recently shown greater interest in healthcare. Pictured, the exterior of the spheres can be seen at Amazon’s headquarters in Seattle

The online retailer recently launched an online pharmacy service, a primary care business, an in-house diagnostic lab and a fitness tracker called Halo.

Amazon CEO Andy Jassy said the company’s venture into medical care was a top priority and could become a “significant disruptor”.

Although things are moving forward, the vaccine would still likely be years away from launch, with anything that comes to market having to go through rigorous FDA trials that take years.

Nor is Amazon the only market player seeking personalized cancer treatment based on DNA sequencing.

Germany-based BioNTech is also working on something similar.